Virtual
This presentation will provide an update on PTAB challenges to biologics patents and their interplay with district court litigation. We will discuss recent IPR and PGR decisions, focusing on those most relevant to biologics patents. We will explore how challengers in the biologics space are using PTAB proceedings as a tool and how their use of PTAB proceedings has changed over time, compare outcomes at the PTAB vs. district courts, and look at how the Board and district courts are currently approaching parallel proceedings and motions to stay litigation pending IPRs or PGRs.
Speakers
Ha Kung Wong, Partner, Venable LLP
Christina Schwarz, Partner, Venable LLP